(1) Dapagliflozin when used as a component of XIGDUO XR, is indicated in adults with type 2 diabetes mellitus to reduce the risk of: Sustained eGFR decline, end-stage kidney disease, cardiovascular death, and hospitalization for heart failure in patients with chronic kidney disease at risk of progression
Clinicians should refer to the BNF and NICE CKS guidance on NSAIDs for full prescribing information
However, the characteristics of the patients included in the clinical trials give some indication
Focus on eating balanced meals with plenty of calcium, vitamin D, and other vitamins that support oral health
Ann Family Med 10(1):1522 Rubin RR (2005) Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus
The future of weight loss pharmacotherapy Ozempic and retatrutide represent two points on a trajectory that is moving fast